|
|
|
|
| LEADER |
00000cam a2200000Mu 4500 |
| 001 |
SCIDIR_on1401069582 |
| 003 |
OCoLC |
| 005 |
20231120010755.0 |
| 006 |
m d |
| 007 |
cr ||||||||||| |
| 008 |
230927s2023 xx o 000 0 eng d |
| 040 |
|
|
|a SFB
|b eng
|c SFB
|d YDX
|d OPELS
|
| 020 |
|
|
|z 9780323955652
|
| 020 |
|
|
|z 0323955657
|
| 035 |
|
|
|a (OCoLC)1401069582
|
| 050 |
|
4 |
|a QR342
|
| 082 |
0 |
4 |
|a 579.26
|2 23/eng/20231010
|
| 245 |
0 |
0 |
|a Phage therapy.
|n Part B /
|c volume editor, Vijai Singh.
|
| 260 |
|
|
|b Academic Press
|c 2023.
|
| 300 |
|
|
|a 1 online resource
|
| 490 |
0 |
|
|a Progress in molecular biology and translational science ;
|v v. 201
|
| 588 |
0 |
|
|a Print version record.
|
| 650 |
|
0 |
|a Bacteriophages
|x Therapeutic use.
|
| 700 |
1 |
|
|a Singh, Vijai,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Phage therapy. Part B.
|z 9780323955652
|w (OCoLC)1400083888
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/bookseries/18771173/201
|z Texto completo
|
